BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22807681)

  • 21. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.
    Martinez-Picado J; Prado JG; Fry EE; Pfafferott K; Leslie A; Chetty S; Thobakgale C; Honeyborne I; Crawford H; Matthews P; Pillay T; Rousseau C; Mullins JI; Brander C; Walker BD; Stuart DI; Kiepiela P; Goulder P
    J Virol; 2006 Apr; 80(7):3617-23. PubMed ID: 16537629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
    Ende Z; Deymier MJ; Claiborne DT; Prince JL; Mónaco DC; Kilembe W; Allen SA; Hunter E
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission.
    Jennes W; Verheyden S; Mertens JW; Camara M; Seydi M; Dieye TN; Mboup S; Demanet C; Kestens L
    Blood; 2013 Feb; 121(7):1157-64. PubMed ID: 23243280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag.
    Littaua RA; Oldstone MB; Takeda A; Debouck C; Wong JT; Tuazon CU; Moss B; Kievits F; Ennis FA
    J Virol; 1991 Aug; 65(8):4051-6. PubMed ID: 1712857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells.
    Merino AM; Sabbaj S; Easlick J; Goepfert P; Kaslow RA; Tang J
    Clin Exp Immunol; 2013 Dec; 174(3):414-23. PubMed ID: 23952339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C.
    Vollmers S; Lobermeyer A; Niehrs A; Fittje P; Indenbirken D; Nakel J; Virdi S; Brias S; Trenkner T; Sauer G; Peine S; Behrens GMN; Lehmann C; Meurer A; Pauli R; Postel N; Roider J; Scholten S; Spinner CD; Stephan C; Wolf E; Wyen C; Richert L; Norman PJ; Sauter J; Schmidt AH; Hoelzemer A; Altfeld M; Körner C
    Front Immunol; 2022; 13():922252. PubMed ID: 35911762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope.
    Nietfield W; Bauer M; Fevrier M; Maier R; Holzwarth B; Frank R; Maier B; Riviere Y; Meyerhans A
    J Immunol; 1995 Mar; 154(5):2189-97. PubMed ID: 7868892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.
    Fogli M; Mavilio D; Brunetta E; Varchetta S; Ata K; Roby G; Kovacs C; Follmann D; Pende D; Ward J; Barker E; Marcenaro E; Moretta A; Fauci AS
    PLoS Pathog; 2008 Jul; 4(7):e1000101. PubMed ID: 18617991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C.
    Sim MJ; Malaker SA; Khan A; Stowell JM; Shabanowitz J; Peterson ME; Rajagopalan S; Hunt DF; Altmann DM; Long EO; Boyton RJ
    Front Immunol; 2017; 8():193. PubMed ID: 28352266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
    Tsai MC; Singh S; Adland E; Goulder P
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-Cw*03-restricted CD8+ T-cell responses targeting the HIV-1 gag major homology region drive virus immune escape and fitness constraints compensated for by intracodon variation.
    Honeyborne I; Codoñer FM; Leslie A; Tudor-Williams G; Luzzi G; Ndung'u T; Walker BD; Goulder PJ; Prado JG
    J Virol; 2010 Nov; 84(21):11279-88. PubMed ID: 20739527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity.
    Chung AW; Mabuka JM; Ndlovu B; Licht A; Robinson H; Ramlakhan Y; Ghebremichael M; Reddy T; Goulder PJR; Walker BD; Ndung'u T; Alter G
    AIDS; 2018 Jun; 32(10):1207-1217. PubMed ID: 29620716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.
    Frazier WR; Steiner N; Hou L; Dakshanamurthy S; Hurley CK
    J Immunol; 2013 Jun; 190(12):6198-208. PubMed ID: 23686481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.
    Moradi S; Stankovic S; O'Connor GM; Pymm P; MacLachlan BJ; Faoro C; Retière C; Sullivan LC; Saunders PM; Widjaja J; Cox-Livingstone S; Rossjohn J; Brooks AG; Vivian JP
    Nat Commun; 2021 Apr; 12(1):2173. PubMed ID: 33846289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.
    Ammaranond P; van Bockel DJ; Petoumenos K; McMurchie M; Finlayson R; Middleton MG; Davenport MP; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD
    J Immunol; 2011 Jan; 186(1):479-88. PubMed ID: 21115730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation.
    Zuo W; Yu XX; Liu XF; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Zhao XS; Huang XJ; Zhao XY
    Front Immunol; 2022; 13():814334. PubMed ID: 35572602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conserved HIV-1 Gag p24 Epitopes Elicit Cellular Immune Responses That Impact Disease Outcome.
    Tarosso LF; Vieira VA; Sauer MM; Tomiyama HI; Kalil J; Kallas EG
    AIDS Res Hum Retroviruses; 2017 Aug; 33(8):832-842. PubMed ID: 28594230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 adaptation to NK-cell-mediated immune pressure.
    Alter G; Heckerman D; Schneidewind A; Fadda L; Kadie CM; Carlson JM; Oniangue-Ndza C; Martin M; Li B; Khakoo SI; Carrington M; Allen TM; Altfeld M
    Nature; 2011 Aug; 476(7358):96-100. PubMed ID: 21814282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
    Davis ZB; Cogswell A; Scott H; Mertsching A; Boucau J; Wambua D; Le Gall S; Planelles V; Campbell KS; Barker E
    PLoS Pathog; 2016 Feb; 12(2):e1005421. PubMed ID: 26828202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.